Invention Grant
- Patent Title: Nanoparticles for use in photodynamic therapies and methods of making, evaluating and using the same
-
Application No.: US17228332Application Date: 2021-04-12
-
Publication No.: US12005125B2Publication Date: 2024-06-11
- Inventor: Andrew Hopkins , Thomas Hopkins
- Applicant: Mi2 Holdings LLC
- Applicant Address: US TX Houston
- Assignee: Mi2 Holdings LLC
- Current Assignee: Mi2 Holdings LLC
- Current Assignee Address: US TX Houston
- Agency: PABST PATENT GROUP LLP
- Main IPC: A61K47/69
- IPC: A61K47/69 ; A61K41/00 ; A61K47/64 ; B82Y5/00 ; B82Y30/00 ; B82Y40/00
Abstract:
A nanocomposition for use in treating cardiac, oncologic, bariatric, or dermatologic indications, conditions and diseases condition using phthalocyanine dye, such as IR700. A nanocomposition having IR700, an 8PEG nanoparticle and a RGD, or iRGD targeting agent. Administering a product comprising IR700 to a patient, whereby the IR700 is delivered to the target tissue, and found in only target tissue; and administering light to activate the IR700, thereby producing an ROS.
Public/Granted literature
- US20210316011A1 Nanoparticles For Use In Photodynamic Therapies And Methods Of Making, Evaluating And Using The Same Public/Granted day:2021-10-14
Information query
